搜索临床试验以:CKD-379(Empagliflozin sitagliptin metformin) Reference drug
总计446个结果
-
AstraZenecaBristol-Myers Squibb完全的
-
The University of Texas Health Science Center at...Baptist Health Foundation of San Antonio招聘中
-
Boehringer IngelheimEli Lilly and Company完全的
-
AstraZenecaBristol-Myers Squibb完全的
-
Merck Sharp & Dohme LLC完全的
-
Hadassah Medical Organization未知
-
AstraZeneca完全的
-
Janssen Research & Development, LLC完全的
-
University Hospital, Gentofte, CopenhagenUniversity of Copenhagen完全的
-
Novo Nordisk A/S完全的2型糖尿病 | 糖尿病大韩民国, 印度, 马来西亚, 火鸡, 阿根廷, 希腊, 澳大利亚, 葡萄牙, 泰国, 巴西
-
AstraZeneca完全的
-
Ludwig-Maximilians - University of MunichMerck Sharp & Dohme LLC完全的
-
Nick Giannoukakis, PhDUniversity of South Florida; AstraZeneca; University of Pittsburgh; National Institutes of Health...完全的
-
Janssen Research & Development, LLC完全的
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 和其他合作者未知
-
Steno Diabetes Center CopenhagenBayer; AstraZeneca; Rigshospitalet, Denmark; The Novo Nordic Foundation完全的
-
Seoul National University Hospital未知
-
Merck Sharp & Dohme LLCPfizer完全的
-
Merck Sharp & Dohme LLC终止
-
Janssen Research & Development, LLC完全的2型糖尿病美国, 加拿大, 法国, 波兰, 德国, 以色列, 印度, 乌克兰, 大韩民国, 马来西亚, 荷兰, 新西兰, 新加坡, 巴西, 奥地利, 丹麦, 比利时
-
AstraZenecaBristol-Myers Squibb完全的
-
University of PaviaIRCCS Policlinico S. Matteo未知
-
Boehringer IngelheimEli Lilly and Company完全的
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)完全的
-
Merck Sharp & Dohme LLCPfizer完全的
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness Network, Canada完全的
-
University of VirginiaEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
University of CologneUmm Al-Qura University; Institute for Biomedical and Pharmaceutical Research (IBMP), Nürnberg-Heroldsberg...完全的